APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psilocybin Assisted Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Psilocybin Assisted Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025194 pages

Choose your research edition.

Industry ResearchPsilocybin Assisted Therapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Psilocybin Assisted Therapy Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Psilocybin Assisted Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psilocybin Assisted Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Psilocybin Assisted Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psilocybin Assisted Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psilocybin Assisted Therapy include ATAI Life Sciences, Compass Pathways, DemeRx, Eleusis, Field Trip, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals, MindMed and Verrian, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Psilocybin Assisted Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Psilocybin Assisted Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Psilocybin Assisted Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Psilocybin Assisted Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Psilocybin Assisted Therapy Segment by Company

ATAI Life Sciences

Compass Pathways

DemeRx

Eleusis

Field Trip

Hikma Pharmaceuticals PLC

Jazz Pharmaceuticals

MindMed

Verrian

Pfizer

Psilocybin Assisted Therapy Segment by Type

Natural

Synthetic

Psilocybin Assisted Therapy Segment by Application

Psychiatric Disorders

Anxiety Disorders

Cluster Headaches

Psilocybin Assisted Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psilocybin Assisted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psilocybin Assisted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psilocybin Assisted Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Psilocybin Assisted Therapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Psilocybin Assisted Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Psilocybin Assisted Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Psilocybin Assisted Therapy Industry Trends Table 2. Psilocybin Assisted Therapy Industry Drivers Table 3. Psilocybin Assisted Therapy Industry Opportunities and Challenges Table 4. Psilocybin Assisted Therapy Industry Restraints Table 5. Global Psilocybin Assisted Therapy Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Psilocybin Assisted Therapy Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers Table 9. Global Psilocybin Assisted Therapy Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Psilocybin Assisted Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Psilocybin Assisted Therapy Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Psilocybin Assisted Therapy Manufacturers, Product Type & Application Table 13. Global Psilocybin Assisted Therapy Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Psilocybin Assisted Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Natural Table 17. Major Manufacturers of Synthetic Table 18. Global Psilocybin Assisted Therapy Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 20. Global Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 21. Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2026) Table 22. Global Psilocybin Assisted Therapy Sales Market Share by Type (2027-2032) Table 23. Global Psilocybin Assisted Therapy Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (K Units) Table 25. Global Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (K Units) Table 26. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2026) Table 27. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Psychiatric Disorders Table 29. Major Manufacturers of Anxiety Disorders Table 30. Major Manufacturers of Cluster Headaches Table 31. Global Psilocybin Assisted Therapy Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 33. Global Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 34. Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2026) Table 35. Global Psilocybin Assisted Therapy Sales Market Share by Application (2027-2032) Table 36. Global Psilocybin Assisted Therapy Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (K Units) Table 38. Global Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (K Units) Table 39. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2026) Table 40. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2027-2032) Table 41. Global Psilocybin Assisted Therapy Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Psilocybin Assisted Therapy Sales by Region (2021-2026) & (K Units) Table 43. Global Psilocybin Assisted Therapy Sales Market Share by Region (2021-2026) Table 44. Global Psilocybin Assisted Therapy Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Psilocybin Assisted Therapy Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 48. North America Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 49. Europe Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 51. Europe Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 58. Global Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Psilocybin Assisted Therapy Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Psilocybin Assisted Therapy Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2021-2026) Table 62. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2027-2032) Table 63. ATAI Life Sciences Company Information Table 64. ATAI Life Sciences Business Overview Table 65. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio Table 67. ATAI Life Sciences Recent Development Table 68. Compass Pathways Company Information Table 69. Compass Pathways Business Overview Table 70. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Compass Pathways Psilocybin Assisted Therapy Product Portfolio Table 72. Compass Pathways Recent Development Table 73. DemeRx Company Information Table 74. DemeRx Business Overview Table 75. DemeRx Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. DemeRx Psilocybin Assisted Therapy Product Portfolio Table 77. DemeRx Recent Development Table 78. Eleusis Company Information Table 79. Eleusis Business Overview Table 80. Eleusis Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Eleusis Psilocybin Assisted Therapy Product Portfolio Table 82. Eleusis Recent Development Table 83. Field Trip Company Information Table 84. Field Trip Business Overview Table 85. Field Trip Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Field Trip Psilocybin Assisted Therapy Product Portfolio Table 87. Field Trip Recent Development Table 88. Hikma Pharmaceuticals PLC Company Information Table 89. Hikma Pharmaceuticals PLC Business Overview Table 90. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio Table 92. Hikma Pharmaceuticals PLC Recent Development Table 93. Jazz Pharmaceuticals Company Information Table 94. Jazz Pharmaceuticals Business Overview Table 95. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio Table 97. Jazz Pharmaceuticals Recent Development Table 98. MindMed Company Information Table 99. MindMed Business Overview Table 100. MindMed Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. MindMed Psilocybin Assisted Therapy Product Portfolio Table 102. MindMed Recent Development Table 103. Verrian Company Information Table 104. Verrian Business Overview Table 105. Verrian Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Verrian Psilocybin Assisted Therapy Product Portfolio Table 107. Verrian Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Pfizer Psilocybin Assisted Therapy Product Portfolio Table 112. Pfizer Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Psilocybin Assisted Therapy Distributors List Table 116. Psilocybin Assisted Therapy Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Psilocybin Assisted Therapy Product Image Figure 2. Global Psilocybin Assisted Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psilocybin Assisted Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Psilocybin Assisted Therapy Sales (2021-2032) & (K Units) Figure 5. Global Psilocybin Assisted Therapy Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Psilocybin Assisted Therapy Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Natural Image Figure 9. Synthetic Image Figure 10. Global Psilocybin Assisted Therapy Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Psilocybin Assisted Therapy Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2032) Figure 13. Global Psilocybin Assisted Therapy Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Psilocybin Assisted Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2032) Figure 16. Psychiatric Disorders Image Figure 17. Anxiety Disorders Image Figure 18. Cluster Headaches Image Figure 19. Global Psilocybin Assisted Therapy Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Psilocybin Assisted Therapy Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2032) Figure 22. Global Psilocybin Assisted Therapy Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Psilocybin Assisted Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2032) Figure 25. North America Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Psilocybin Assisted Therapy Sales Market Share by Country (2021-2032) Figure 27. U.S. Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2021-2032) Figure 32. Germany Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Psilocybin Assisted Therapy Sales Market Share by Country (2021-2032) Figure 39. China Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Psilocybin Assisted Therapy Sales Market Share by Country (2021-2032) Figure 47. Brazil Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Psilocybin Assisted Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Psilocybin Assisted Therapy Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Psilocybin Assisted Therapy Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Figure 58. North America Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Figure 60. Europe Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Psilocybin Assisted Therapy Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Psilocybin Assisted Therapy Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Natural
  • Synthetic
Applications
  • Psychiatric Disorders
  • Anxiety Disorders
  • Cluster Headaches
Companies covered
  • ATAI Life Sciences
  • Compass Pathways
  • DemeRx
  • Eleusis
  • Field Trip
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals
  • MindMed
  • Verrian
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Psilocybin Assisted Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Psilocybin Assisted Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Psilocybin Assisted Therapy Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Psilocybin Assisted Therapy Market Dynamics
  1. 2.1 Psilocybin Assisted Therapy Industry Trends
  2. 2.2 Psilocybin Assisted Therapy Industry Drivers
  3. 2.3 Psilocybin Assisted Therapy Industry Opportunities and Challenges
  4. 2.4 Psilocybin Assisted Therapy Industry Restraints
3 Psilocybin Assisted Therapy Market by Manufacturers
  1. 3.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Psilocybin Assisted Therapy Sales by Manufacturers (2021-2026)
  3. 3.3 Global Psilocybin Assisted Therapy Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Psilocybin Assisted Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psilocybin Assisted Therapy Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Psilocybin Assisted Therapy Manufacturers, Product Type & Application
  7. 3.7 Global Psilocybin Assisted Therapy Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psilocybin Assisted Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psilocybin Assisted Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psilocybin Assisted Therapy Tier 1, Tier 2, and Tier 3
4 Psilocybin Assisted Therapy Market by Type
  1. 4.1 Psilocybin Assisted Therapy Type Introduction
  2. 4.1.1 Natural
  3. 4.1.2 Synthetic
  4. 4.2 Global Psilocybin Assisted Therapy Sales by Type
  5. 4.2.1 Global Psilocybin Assisted Therapy Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Psilocybin Assisted Therapy Sales by Type (2021-2032)
  7. 4.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2032)
  8. 4.3 Global Psilocybin Assisted Therapy Revenue by Type
  9. 4.3.1 Global Psilocybin Assisted Therapy Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  11. 4.3.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2032)
5 Psilocybin Assisted Therapy Market by Application
  1. 5.1 Psilocybin Assisted Therapy Application Introduction
  2. 5.1.1 Psychiatric Disorders
  3. 5.1.2 Anxiety Disorders
  4. 5.1.3 Cluster Headaches
  5. 5.2 Global Psilocybin Assisted Therapy Sales by Application
  6. 5.2.1 Global Psilocybin Assisted Therapy Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 5.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2032)
  9. 5.3 Global Psilocybin Assisted Therapy Revenue by Application
  10. 5.3.1 Global Psilocybin Assisted Therapy Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  12. 5.3.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2032)
6 Global Psilocybin Assisted Therapy Sales by Region
  1. 6.1 Global Psilocybin Assisted Therapy Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Psilocybin Assisted Therapy Sales by Region (2021-2032)
  3. 6.2.1 Global Psilocybin Assisted Therapy Sales by Region (2021-2026)
  4. 6.2.2 Global Psilocybin Assisted Therapy Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Psilocybin Assisted Therapy Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Psilocybin Assisted Therapy Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Psilocybin Assisted Therapy Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Psilocybin Assisted Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Psilocybin Assisted Therapy Revenue by Region
  1. 7.1 Global Psilocybin Assisted Therapy Revenue by Region
  2. 7.1.1 Global Psilocybin Assisted Therapy Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Psilocybin Assisted Therapy Revenue by Region (2021-2026)
  4. 7.1.3 Global Psilocybin Assisted Therapy Revenue by Region (2027-2032)
  5. 7.1.4 Global Psilocybin Assisted Therapy Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Psilocybin Assisted Therapy Revenue (2021-2032)
  8. 7.2.2 North America Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Psilocybin Assisted Therapy Revenue (2021-2032)
  11. 7.3.2 Europe Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Psilocybin Assisted Therapy Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Psilocybin Assisted Therapy Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Psilocybin Assisted Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ATAI Life Sciences
  2. 8.1.1 ATAI Life Sciences Company Information
  3. 8.1.2 ATAI Life Sciences Business Overview
  4. 8.1.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
  6. 8.1.5 ATAI Life Sciences Recent Developments
  7. 8.2 Compass Pathways
  8. 8.2.1 Compass Pathways Company Information
  9. 8.2.2 Compass Pathways Business Overview
  10. 8.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
  12. 8.2.5 Compass Pathways Recent Developments
  13. 8.3 DemeRx
  14. 8.3.1 DemeRx Company Information
  15. 8.3.2 DemeRx Business Overview
  16. 8.3.3 DemeRx Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
  18. 8.3.5 DemeRx Recent Developments
  19. 8.4 Eleusis
  20. 8.4.1 Eleusis Company Information
  21. 8.4.2 Eleusis Business Overview
  22. 8.4.3 Eleusis Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
  24. 8.4.5 Eleusis Recent Developments
  25. 8.5 Field Trip
  26. 8.5.1 Field Trip Company Information
  27. 8.5.2 Field Trip Business Overview
  28. 8.5.3 Field Trip Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
  30. 8.5.5 Field Trip Recent Developments
  31. 8.6 Hikma Pharmaceuticals PLC
  32. 8.6.1 Hikma Pharmaceuticals PLC Company Information
  33. 8.6.2 Hikma Pharmaceuticals PLC Business Overview
  34. 8.6.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
  36. 8.6.5 Hikma Pharmaceuticals PLC Recent Developments
  37. 8.7 Jazz Pharmaceuticals
  38. 8.7.1 Jazz Pharmaceuticals Company Information
  39. 8.7.2 Jazz Pharmaceuticals Business Overview
  40. 8.7.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
  42. 8.7.5 Jazz Pharmaceuticals Recent Developments
  43. 8.8 MindMed
  44. 8.8.1 MindMed Company Information
  45. 8.8.2 MindMed Business Overview
  46. 8.8.3 MindMed Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MindMed Psilocybin Assisted Therapy Product Portfolio
  48. 8.8.5 MindMed Recent Developments
  49. 8.9 Verrian
  50. 8.9.1 Verrian Company Information
  51. 8.9.2 Verrian Business Overview
  52. 8.9.3 Verrian Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
  54. 8.9.5 Verrian Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Psilocybin Assisted Therapy Value Chain Analysis
  2. 9.1.1 Psilocybin Assisted Therapy Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Psilocybin Assisted Therapy Production Mode & Process
  6. 9.2 Psilocybin Assisted Therapy Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Psilocybin Assisted Therapy Distributors
  9. 9.2.3 Psilocybin Assisted Therapy Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst